Diagnostic criteria | Duration of complaints (weeks) | Orthotic group (O) | Control group (C) | Follow-up time (weeks) | Outcome measure | Change scores* | Mean difference (95% CI)† | Effect size | ||
---|---|---|---|---|---|---|---|---|---|---|
Treatment | No of subjects | Treatment | No of subjects | |||||||
RCTs of knee braces and exercise therapy vs exercise therapy only | ||||||||||
Denton et al15 | ||||||||||
PFPS 34% female Age: 13–55 years Mean (SD): 28 (?) | >4 | Protonics system and exercise therapy | 17 | Exercise therapy | 17 | 6 | Pain: VPS during: | |||
Lateral step-up test | O: 4.6¶ | 1.3‡ | ‡ | |||||||
C: 3.3¶ | ||||||||||
Function: KPS | O: 28.9¶ | 4.9‡ | ‡ | |||||||
C: 24¶ | ||||||||||
Performance: Step-up test | O: 4¶ | −1‡ | ‡ | |||||||
C: 5¶ | ||||||||||
Miller et al19 | ||||||||||
AKP 19% female Age: ? | 3 | Palumbo dynamic patellar brace and exercise therapy | 20 | Exercise therapy | 13 | 2–3 | Pain: VAS during: | |||
Activity | O: 2.04 | 1.35‡ | ‡ | |||||||
C: 0.69 | ||||||||||
Cho Pad knee strap and exercise therapy | 18 | Exercise therapy | 13 | 2–3 | Pain: VAS during activity | O: 1.78 | 1.09‡ | ‡ | ||
C: 0.69 | ||||||||||
Lun et al18 | ||||||||||
PFPS 79% female Age: 18–60 years Mean (SD): 35 (?) | 2 | Home exercise therapy and a Y-shaped patellar brace | 32 | Home exercise therapy | 34 | 12 | Pain: VAS during: | |||
Sport activity | O: 1.5 | 0 (−0.61 to 0.61) | 0 | |||||||
C: 1.5 | ||||||||||
1 h after sport activity | O: 1.5 | −0.4 (−0.95 to 0.15) | −0.14 | |||||||
C: 1.9 | ||||||||||
Following 30 min of sitting with flexed knees | O: 1.5 | 0.1 (−0.53 to 0.83) | 0.04 | |||||||
C: 1.4 | ||||||||||
Function: KF | O: 2 | −3 (−5.06 to −0.95)§ | −0.33 | |||||||
C: 5 | ||||||||||
RCT of knee braces and exercise therapy vs placebo braces and exercise therapy | ||||||||||
Lun et al18 | ||||||||||
PFPS 79% female Age: 18–60 years Mean (SD): 35 (?) | 2 | Home exercise therapy and a Y-shaped patellar brace | 32 | Home exercise therapy and knee sleeve | 31 | 12 | Pain: VAS during: | |||
Sport activity | O: 1.6 | 0.1 (−0.57 to 0.77) | 0.03 | |||||||
C: 1.5 | ||||||||||
1 h after sport activity | O: 2.2 | 0.3 (−0.28 to 0.88) | 0.10 | |||||||
C: 1.9 | ||||||||||
Following 30 min of sitting with flexed knees | O: 1.6 | 0.2 (−0.47 to 0.87) | 0.06 | |||||||
C: 1.4 | ||||||||||
Function: KF | O: 4 | −1 (−2.98 to 0.98) | −0.12 | |||||||
C: 5 | ||||||||||
RCT of tape and exercise therapy vs exercise therapy only | ||||||||||
Whittingham et al20 | ||||||||||
PFPS 20% female Age: 17–25 years Mean (SD) 18.7 (1.2) | ? | Medially directed tape and exercise therapy | 10 | Exercise therapy | 10 | 4 | Pain: VAS during: | |||
Pervious 24 h | O: 7.5C: 5.7 | 1.8 (1.60 to 2.00)§ | 2.00 | |||||||
A step test without tape | O: 7.4 | 1.7 (1.50 to 1.99)§ | 1.89 | |||||||
C: 5.7 | ||||||||||
Function: FIQ | O: 8.4 | 2.6 (2.38 to 2.82)§ | 2.89 | |||||||
C: 5.8 | ||||||||||
Clark et al13 | ||||||||||
AKP/PFPS 44% female Age: 15–40 years Mean (SD) ? | >12 | Education, exercise therapy and tape | 20 | Education and exercise therapy | 20 | 12 | Pain: Mean VAS during: | |||
Climbing stairs and walking | O: 39.7 | −7.4 (−18.03 to 3.23) | −0.19 | |||||||
C: 47.1 | ||||||||||
Function: WOMAC | O: 13.7 | 0 (−3.45 to 3.45) | 0 | |||||||
C: 13.7 | ||||||||||
52 | Pain: Mean VAS during climbing stairs and walking | O: 40.0 | 0.7 (−6.30 to 7.70) | 0.02 | ||||||
C: 39.3 | ||||||||||
Function: WOMAC | O: 10.4C: 8.1 | 2.3 (−3.00 to 7.60) | 0.18 | |||||||
Kowall et al17 | ||||||||||
?68% female Age: 14–40 years Mean (SD) 29 (?) | >4 | Exercise therapy and tape | 12 | Exercise therapy | 13 | 4 | Pain: VAS | O: 14¶ | 0‡ | 0 |
C: 14¶ | ||||||||||
RCT of tape and exercise therapy vs placebo tape and exercise therapy | ||||||||||
Whittingham et al20 | ||||||||||
PFPS 20% female Age: 17–25 years Mean (SD) 18.7 (1.2) | ? | Medially directed tape and exercise therapy | 10 | Placebo tape and exercise therapy | 10 | 4 | Pain: VAS during: | |||
Pervious 24 h | O: 7.5 | 0.9 (0.75 to 1.05)§ | 1.00 | |||||||
C: 6.6 | ||||||||||
A step test without tape | O: 7.4 | 1.1 (0.99 to 1.21)§ | 1.38 | |||||||
C: 6.3 | ||||||||||
Function: FIQ | O: 8.4 | 2.7 (2.46 to 2.94)§ | 3 | |||||||
C: 5.7 | ||||||||||
RCT of foot orthotics and exercise therapy vs exercise therapy only | ||||||||||
Collins et al14 | ||||||||||
PFPS 55.9% female Age: 18–40 years Mean (SD) 29.3 (5.8) | >6 | Exercise therapy and foot orthotics | 44 | Exercise therapy | 45 | 6 | Pain: VAS for: | |||
Usual pain | O: 19.4 | −1.8 (−5.40 to 1.80) | −0.10 | |||||||
C: 21.2 | ||||||||||
Worst pain | O: 28.5 | −3.6 (−5.90 to 1.29) | −0.22 | |||||||
C: 32.2 | ||||||||||
Function: KPS | O: 83.6 | 0.2 (−1.69 to 2.09) | 0.02 | |||||||
C: 83.4 | ||||||||||
Function: FIQ | O: 13.3 | 0.5 (0.26 to 0.74)§ | 0.22 | |||||||
C: 12.9 | ||||||||||
52 | Pain: VAS for: | |||||||||
Usual pain | O: 14.4 | 0.4 (−3.45 to 4.25) | 0.02 | |||||||
C: 13.9 | ||||||||||
Worst pain | O: 18.8 | −3.3 (−8.24 to 1.64) | 0.20 | |||||||
C: 22.2 | ||||||||||
Function: KPS | O: 91.5 | 3.6 (1.58 to 5.61)§ | 0.34 | |||||||
C: 87.9 | ||||||||||
Function: FIQ | O: 13.8 | −0.5 (−1.04 to 0.04) | −0.22 | |||||||
C: 14.2 | ||||||||||
Eng and Pierrynowski16 | ||||||||||
PFPS 100% female Age: 13–17 years Mean (SD) 14.8 (1.2) | >6 | Exercise therapy and foot orthotics | 10 | Exercise therapy | 10 | 6 | Pain: VAS during: | |||
Walking | O: 2¶ | 1.5‡ | ‡ | |||||||
C: 0.5¶ | ||||||||||
Running | O: 3¶ | 2.5‡§ | ‡ | |||||||
C: 0.5¶ |
↵? indicates unknown/not reported.
↵* Change scores in the O and C group. Positive scores indicate improvement, ie, less pain or better function.
↵† Difference in change scores between O and C.
↵‡ Not enough information was provided to make this assessment.
↵§ Significant difference between orthotics group and control group.
↵¶ Data abstracted from figures.
AKP, anterior knee pain; FIQ, functional index questionnaire (0–16); KF, knee function scale (0–53); KPS, Kujala patellofemoral score (0–100); PFPS, patellofemoral pain syndrome; RCT, randomised controlled trial; VAS, visual analogue scale score (0–100); VPS, verbal pain score (0–10); WOMAC, Western Ontario and McMaster Universities Osteoarthritis Questionnaire (0–100).